Entries by Lisa Langbein

A CLINICALLY APPLICABLE CONNECTIVITY SIGNATURE FOR GLIOBLASTOMA INCLUDES THE TUMOR NETWORK DRIVER CHI3L1

Research findings related to UNITE work package A03 Tumor microtubes (TMs) connect glioma cells to a network with considerable relevance for tumor progression and therapy resistance. However, the determination of TM-interconnectivity in individual tumors is challenging and the impact on patient survival unresolved. Here, we establish a connectivity signature from single-cell RNA-sequenced (scRNA-Seq) xenografted primary […]

AUTONOMOUS RHYTHMIC ACTIVITY IN GLIOMA NETWORKS DRIVES BRAIN TUMOR GROWTH

  Research findings related to UNITE work package A01 Diffuse gliomas, particularly glioblastomas, are incurable brain tumours. They are characterized by networks of interconnected brain tumour cells that communicate via Ca2+ transients. However, the networks’ architecture and communication strategy and how these influence tumour biology remain unknown. Here we describe how glioblastoma cell networks include a […]

CANCER NEUROSCIENCE: STATE OF THE FIELD, EMERGING DIRECTIONS

Research findings related to UNITE work package A01 The nervous system governs both ontogeny and oncology. Regulating organogenesis during development, maintaining homeostasis, and promoting plasticity throughout life, the nervous system plays parallel roles in the regulation of cancers. Foundational discoveries have elucidated direct paracrine and electrochemical communication between neurons and cancer cells, as well as indirect interactions through neural effects on the […]

PROGNOSTIC MARKERS OF DNA METHYLATION AND NGS SEQUENCING IN PROGRESSIVE GLIOBLASTOMA FROM THE EORTC-26101 TRIAL

Research findings related to UNITE work package A01 Purpose: The EORTC-26101 study was a randomized phase II and III clinical trial of bevacizumab in combination with lomustine versus lomustine alone in progressive glioblastoma. Other than for progression-free survival (PFS), there was no benefit from addition of bevacizumab for overall survival (OS). However, molecular data allow for […]